IRIDEX Corporation Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • IRIDEX Corporation's estimated annual revenue is currently $35M per year.(i)
  • IRIDEX Corporation's estimated revenue per employee is $175,879

Employee Data

  • IRIDEX Corporation has 199 Employees.(i)
  • IRIDEX Corporation grew their employee count by 10% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19.6M62-6%N/AN/A
#2
$3.5M26-10%N/AN/A
#3
$5.5M1912%N/AN/A
#4
$3.3M320%N/AN/A
#5
$5.8M18-10%N/AN/A
#6
$49.7M1623%N/AN/A
#7
$9.8M39N/AN/AN/A
#8
$2.9M2723%N/AN/A
#9
$27.4M85-8%N/AN/A
#10
$4.5M4323%N/AN/A
Add Company

IRIDEX Corporation is a worldwide leader in developing, manufacturing, marketing and selling innovative and cost-effective medical laser systems for the ophthalmic and aesthetic markets. The Company has the largest global installed base of solid-state lasers and focuses on developing laser products that are clinically effective, reliable, portable, versatile, and affordable.

keywords:N/A

N/A

Total Funding

199

Number of Employees

$35M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

IRIDEX Corporation News

2022-04-19 - Best Research Report on Ophthalmic Surgical Systems ...

... to 2028: Ziemer Group, Volk, Abbott Laboratories, IRIDEX Corporation ... Request More Information on this Report (Use Corporate eMail ID...

2022-04-17 - IRIDEX (NASDAQ:IRIX) Receives New Coverage from ...

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable...

2022-03-30 - Do Analysts Agree Monday on IRIDEX Corporation (IRIX) Stock's Target Price?

Do Analysts Agree Monday on IRIDEX Corporation (IRIX) Stock's Target Price? Monday, March 28, 2022 10:50 AM | InvestorsObserver Analysts. Do Analysts Agree...

2016-02-16 - IRIDEX moves forward in commercialization of laser system to treat glaucoma

The Cyclo G6 Laser System will be sold with two disposable probes, the MicroPulse P3 probe for use with a broad range of glaucoma patients and the G-Probe for later stage patients. IRIDEX plans to introduce a series of additional new probes in the coming year that allow for additional applicatio ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$31.5M19945%$14.5M
#2
$76.2M19957%$121M
#3
$70.9M20017%N/A
#4
$47.7M20238%$150.1M
#5
$17.4M20238%N/A